Page last updated: 2024-08-24

dexmedetomidine and Encephalopathy, Traumatic

dexmedetomidine has been researched along with Encephalopathy, Traumatic in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's15 (53.57)24.3611
2020's13 (46.43)2.80

Authors

AuthorsStudies
Cakir-Aktas, C; Karakaya, D; Mut, M; Soylemezoglu, F; Uzun, S1
Anstey, J; Bellomo, R; Jeffcote, T; Mcnamara, R; Udy, A; Weir, T1
Badulescu, AV; Burlacu, CC; Buzoianu, AD; Mitre, AO; Neag, MA; Sirbu, AC1
Xiao, Q; Xu, J1
Cox, CS; Haase, CM; Olson, SD; Scott, MC1
Chen, W; Huang, H; Miao, H; Su, YY; Zhang, Y1
Gao, J; Liu, Y; Ren, C; Wei, L; Xu, G; Zhang, Z1
Gao, P; Li, F; Wang, X; Zhang, X; Zhang, Z1
Doğan, G; Karaca, O1
Fan, Y; Liu, X; Sun, D; Wang, J; Yang, M; Zhang, J1
Li, H; Lu, C; Xu, L; Yao, W; Zheng, B; Zhou, J1
Albert, M; Bernard, F; Bilodeau, V; Burry, L; Frenette, AJ; Saavedra-Mitjans, M; Williamson, DR1
Hao, FG; Huang, GR1
Feng, X; Jiao, W; Ma, W; Wang, Y; Zhu, J1
Kii, N; Sawada, A; Tachibana, S; Yamakage, M; Yoshikawa, Y1
Han, XR; Lu, J; Shen, M; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, MH; Zheng, YL; Zhou, XM1
Chen, J; Gao, X; Kulwin, C; Lin, B; Vogel, T; Wu, J1
Cui, JZ; Feng, Y; Wang, KJ; Zhang, HA; Zhang, MH; Zhou, XM1
Bindra, A; Chouhan, RS; Radhakrishna, N; Singh, S1
Bo, L; Deng, X; Wang, C; Wang, H; Wang, Y; Zhang, D1
Guo, X; Li, H; Ruan, X; Xu, L; Ying, Y; Zhang, S; Zheng, B1
Alam, A; Hana, Z; Jin, Z; Ma, D; Suen, KC1
Deng, Z; Gao, P; Li, F; Liu, H; Wang, X; Zhang, X1
Longrois, D; Quintin, L1
Constantin, JM; Perbet, S1
Godoy, DA; Lubillo-Montenegro, S; Murillo-Cabezas, F; Tolosa, K1
Bonds, BW; Boswell, S; Devabhakthuni, S; Hesselton, K; Kufera, JA; Pajoumand, M; Scalea, TM; Stein, DM1
Humble, SS; Leath, TC; Marshall, MD; Pandharipande, PP; Patel, MB; Sun, DZ; Wilson, LD1

Reviews

3 review(s) available for dexmedetomidine and Encephalopathy, Traumatic

ArticleYear
The Impact of Sedative Choice on Intracranial and Systemic Physiology in Moderate to Severe Traumatic Brain Injury: A Scoping Review.
    Journal of neurosurgical anesthesiology, 2023, Jul-01, Volume: 35, Issue:3

    Topics: Adult; Analgesics, Opioid; Brain Injuries; Brain Injuries, Traumatic; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intracranial Hypertension; Ketamine; Propofol; Prospective Studies

2023
The Role of miRNAs in Dexmedetomidine's Neuroprotective Effects against Brain Disorders.
    International journal of molecular sciences, 2022, May-13, Volume: 23, Issue:10

    Topics: Anesthetics; Brain Injuries, Traumatic; Dexmedetomidine; Humans; MicroRNAs; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxicity Syndromes

2022
Surgery, neuroinflammation and cognitive impairment.
    EBioMedicine, 2018, Volume: 37

    Topics: Animals; Brain Injuries, Traumatic; Cognitive Dysfunction; Dementia; Dexmedetomidine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibuprofen; Inflammation; Postoperative Complications

2018

Trials

3 trial(s) available for dexmedetomidine and Encephalopathy, Traumatic

ArticleYear
Effects of dexmedetomidine vs sufentanil during percutaneous tracheostomy for traumatic brain injury patients: A prospective randomized controlled trial.
    Medicine, 2019, Volume: 98, Issue:35

    Topics: Adult; Brain Injuries, Traumatic; Cough; Dexmedetomidine; Female; Hemodynamics; Humans; Hypnotics and Sedatives; Laryngismus; Male; Middle Aged; Prospective Studies; Sufentanil; Tracheostomy

2019
Comparison of effect of dexmedetomidine and lidocaine on intracranial and systemic hemodynamic response to chest physiotherapy and tracheal suctioning in patients with severe traumatic brain injury.
    Journal of anesthesia, 2018, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Brain Injuries, Traumatic; Dexmedetomidine; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Intracranial Pressure; Lidocaine; Male; Middle Aged; Physical Therapy Modalities; Prospective Studies; Respiration, Artificial; Suction; Young Adult

2018
Cooperative sedation: An option for the management of agitation in moderate traumatic brain injury.
    Medicina intensiva, 2017, Volume: 41, Issue:3

    Topics: Accidental Falls; Accidents, Traffic; Adult; Aged, 80 and over; Analgesics; Brain Injuries, Traumatic; Clinical Protocols; Conscious Sedation; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Intensive Care Units; Male; Middle Aged; Psychomotor Agitation; Tomography, X-Ray Computed; Trauma Severity Indices; Young Adult

2017

Other Studies

22 other study(ies) available for dexmedetomidine and Encephalopathy, Traumatic

ArticleYear
Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury.
    Neurocritical care, 2022, Volume: 36, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Dexmedetomidine; Disease Models, Animal; Humans; Interleukin-1beta; Mice; Neuroinflammatory Diseases; NLR Family, Pyrin Domain-Containing 3 Protein

2022
Assessment of the effects of dexmedetomidine on outcomes of traumatic brain injury using propensity score analysis.
    BMC anesthesiology, 2022, 09-02, Volume: 22, Issue:1

    Topics: Brain Injuries; Brain Injuries, Traumatic; Dexmedetomidine; Glasgow Coma Scale; Humans; Hypotension; Propensity Score; Seizures

2022
Dexmedetomidine Alters the Inflammatory Profile of Rat Microglia In Vitro.
    Neurocritical care, 2023, Volume: 38, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brain Injuries, Traumatic; Cytokines; Dexmedetomidine; Inflammation; Interleukin-10; Lipopolysaccharides; Microglia; Poly I; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

2023
Clinical characteristics and prognosis of paroxysmal sympathetic hyperactivity in patients with severe nontraumatic brain injury.
    Brain injury, 2023, 01-28, Volume: 37, Issue:2

    Topics: Autonomic Nervous System Diseases; Brain Injuries; Brain Injuries, Traumatic; Dexmedetomidine; Humans; Prognosis; Prospective Studies

2023
Dexmedetomidine Attenuates Neuroinflammatory-Induced Apoptosis after Traumatic Brain Injury via Nrf2 signaling pathway.
    Annals of clinical and translational neurology, 2019, Volume: 6, Issue:9

    Topics: Animals; Apoptosis; Brain; Brain Injuries, Traumatic; Dexmedetomidine; Inflammation; Neuroprotective Agents; NF-E2-Related Factor 2; Rats; Signal Transduction

2019
The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study.
    Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2020, Volume: 26, Issue:1

    Topics: Animals; Brain Injuries, Traumatic; Cytokines; Dexmedetomidine; Disease Models, Animal; Inflammation; Intestinal Absorption; Intestinal Mucosa; Rats

2020
Dexmedetomidine attenuates endoplasmic reticulum stress-induced apoptosis and improves neuronal function after traumatic brain injury in mice.
    Brain research, 2020, 04-01, Volume: 1732

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Brain; Brain Injuries, Traumatic; Dexmedetomidine; Endoplasmic Reticulum Stress; Male; Mice; Neurons; Neuroprotective Agents

2020
Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury.
    Aging, 2020, 11-04, Volume: 12, Issue:21

    Topics: Animals; Anti-Inflammatory Agents; Autophagy; Behavior, Animal; Brain; Brain Injuries, Traumatic; Dexmedetomidine; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Male; MicroRNAs; Rats, Sprague-Dawley; RNA, Circular; Signal Transduction

2020
Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study.
    Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Behavioral Symptoms; Benzodiazepines; Body Weight; Brain Injuries, Traumatic; Comorbidity; Critical Illness; Dexmedetomidine; Drug Therapy, Combination; Female; Glasgow Coma Scale; Humans; Hypnotics and Sedatives; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Sex Factors; Substance-Related Disorders; Trauma Severity Indices

2021
Dexmedetomidine Inhibits Inflammation to Alleviate Early Neuronal Injury via TLR4/NF-κB Pathway in Rats with Traumatic Brain Injury.
    Critical reviews in eukaryotic gene expression, 2021, Volume: 31, Issue:1

    Topics: Animals; Apoptosis; Autophagy; Brain Injuries, Traumatic; Cytokines; Dexmedetomidine; Disease Models, Animal; Inflammation; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4

2021
Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway.
    Molecular medicine reports, 2021, Volume: 24, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Autophagy; Beclin-1; Brain; Brain Injuries; Brain Injuries, Traumatic; Cell Survival; Cytokines; Dexmedetomidine; Disease Models, Animal; Female; Male; Mice; Mice, Inbred C57BL; Neuroinflammatory Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; Reactive Oxygen Species; Signal Transduction

2021
Dexmedetomidine Ameliorates Perioperative Neurocognitive Disorders by Suppressing Monocyte-Derived Macrophages in Mice With Preexisting Traumatic Brain Injury.
    Anesthesia and analgesia, 2022, 04-01, Volume: 134, Issue:4

    Topics: Animals; Brain Injuries, Traumatic; Dexmedetomidine; Humans; Interleukin-1beta; Macrophages; Male; Mice; Mice, Inbred C57BL; Neurocognitive Disorders

2022
Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 95

    Topics: Animals; Apoptosis; Avoidance Learning; Beclin-1; Blotting, Western; Brain; Brain Injuries, Traumatic; Claudin-5; Cytokines; Dexmedetomidine; Enzyme-Linked Immunosorbent Assay; Inflammation Mediators; Microtubule-Associated Proteins; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Zonula Occludens-1 Protein

2017
Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury.
    Scientific reports, 2018, 03-21, Volume: 8, Issue:1

    Topics: Animals; Brain Injuries, Traumatic; Cerebral Cortex; Dexmedetomidine; Disease Models, Animal; Hippocampus; Male; Mice; Neuroprotective Agents

2018
Neuroprotective effects of dexmedetomidine on traumatic brain injury: Involvement of neuronal apoptosis and HSP70 expression.
    Molecular medicine reports, 2018, Volume: 17, Issue:6

    Topics: Animals; Apoptosis; Biomarkers; Brain Edema; Brain Injuries, Traumatic; Dexmedetomidine; Hippocampus; HSP70 Heat-Shock Proteins; Immunohistochemistry; Male; Neurons; Neuroprotective Agents; Rats; Spatial Learning

2018
Dexmedetomidine Protects Against Traumatic Brain Injury-Induced Acute Lung Injury in Mice.
    Medical science monitor : international medical journal of experimental and clinical research, 2018, Jul-17, Volume: 24

    Topics: Acute Lung Injury; Animals; Brain Injuries, Traumatic; Bronchoalveolar Lavage Fluid; Dexmedetomidine; HMGB1 Protein; Lung; Male; Mice; Mice, Inbred C57BL; Models, Animal; Protective Agents; Pulmonary Edema; Receptor for Advanced Glycation End Products; Signal Transduction

2018
Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats.
    Bioscience reports, 2018, 10-31, Volume: 38, Issue:5

    Topics: Animals; Brain Injuries, Traumatic; Caspase 1; Dexmedetomidine; Disease Models, Animal; Hippocampus; Humans; Inflammasomes; Microglia; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Rats

2018
Dexmedetomidine reduces oxidative stress and provides neuroprotection in a model of traumatic brain injury via the PGC-1α signaling pathway.
    Neuropeptides, 2018, Volume: 72

    Topics: Animals; Apoptosis; Brain; Brain Injuries, Traumatic; Dexmedetomidine; Male; Neuroprotective Agents; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Signal Transduction

2018
Dexmedetomidine: Superiority trials needed?
    Anaesthesia, critical care & pain medicine, 2016, Volume: 35, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Brain Injuries, Traumatic; Contraindications; Critical Care; Deep Sedation; Dexmedetomidine; Humans; Hypnotics and Sedatives; Respiratory Distress Syndrome

2016
Dexmedetomidine: Superiority trials needed? Reply.
    Anaesthesia, critical care & pain medicine, 2016, Volume: 35, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Brain Injuries, Traumatic; Contraindications; Critical Care; Deep Sedation; Dexmedetomidine; Humans; Hypnotics and Sedatives; Respiratory Distress Syndrome

2016
Dexmedetomidine as an adjunct for sedation in patients with traumatic brain injury.
    The journal of trauma and acute care surgery, 2016, Volume: 81, Issue:2

    Topics: Abbreviated Injury Scale; Adult; Baltimore; Brain Injuries, Traumatic; Dexmedetomidine; Female; Glasgow Coma Scale; Humans; Hypnotics and Sedatives; Hypotension; Male; Prospective Studies; Treatment Outcome

2016
ICU sedation with dexmedetomidine after severe traumatic brain injury.
    Brain injury, 2016, Volume: 30, Issue:10

    Topics: Adult; Analgesics, Non-Narcotic; Blood Pressure; Brain Injuries, Traumatic; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Young Adult

2016